Date on Master's Thesis/Doctoral Dissertation
8-2025
Document Type
Master's Thesis
Degree Name
M.S.
Department
Pharmacology and Toxicology
Degree Program
Pharmacology and Toxicology, MS
Committee Chair
Watson, Walter
Committee Co-Chair (if applicable)
Cave, Matthew
Committee Member
Srivastava, Sanja
Committee Member
Kidd, La Creis
Committee Member
Wahlang, Banrida
Author's Keywords
Alcohol-associated liver disease; PFOS; enviornmental liver disease; nuclear receptors
Abstract
Perfluorooctane sulfonate (PFOS), a pervasive environmental pollutant, has been increasingly associated with the development of metabolic dysfunction-associated steatotic liver disease (MASLD); nonetheless, its connections with alcohol-associated liver disease (ALD) have not been well studied. This study investigates the hypothesis that PFOS exposure alters hepatic metabolism, thereby leading to alterations in ALD severity. Male C57BL/6J mice were fed isocaloric control or 5% ethanol (EtOH) diet for 15 days. From day 6 of feeding, mice were concurrently gavaged with 1 mg/kg PFOS or 2% Tween-80 vehicle for 10 days, followed by a 5 g/kg EtOH binge dose. PFOS and ethanol co-exposure significantly increased transcription of several notable transcription factors including peroxisome proliferator-activated receptor alpha (PPARα), constitutive androstane receptor (CAR), and pregnane x receptor (PXR). Furthermore, dual-exposure worsened ALD severity by increasing liver injury, steatosis, lipid dysregulation, and by enriching hepatic transcriptional pathways. Overall, these findings suggest that PFOS worsens ALD severity.
Recommended Citation
Brizendine/Ames, Paxton Michelle, "Effects of perfluorooctane sulfonate in a mouse model of alcohol-associated liver disease." (2025). Electronic Theses and Dissertations. Paper 4596.
Retrieved from https://ir.library.louisville.edu/etd/4596